The Clinical Definition: What Is a Longevity Doctor?
A longevity doctor is a licensed physician (MD, DO, or MBBS) trained in aging biology and dedicated to extending healthspan through evidence-based interventions targeting the mechanisms of aging. Unlike traditional physicians who diagnose and treat disease after it emerges, a longevity physician assesses biological age and intervenes before disease develops.
Longevity medicine is real medicine: practiced by physicians, grounded in evidence, and accountable to professional standards. The wellness field gets confused with wellness theater, optimization trends, and the biohacking content flooding social media often enough that the distinction is worth making explicit.
A longevity physician understands the hallmarks of aging: cellular senescence, mitochondrial dysfunction, inflammaging, telomere attrition, epigenetic drift, loss of proteostasis, disabled macroautophagy, stem cell exhaustion, and altered intercellular communication. Just as important, they know how to translate that understanding into clinical practice: assessing biological age with objective biomarkers, prescribing interventions based on mechanism rather than marketing, documenting outcomes, and staying accountable to professional standards.
Human healthspan is one of the most important challenges in modern medicine. Meeting that challenge requires the same rigor, infrastructure, and institutional credibility that define every established medical specialty, and physicians are the ones with the training and accountability to build it. The Longevity Medicine Manifesto, 2026
Why This Matters Now: The Market Signal
Signal 1: Patient Demand Has Already Arrived
Patients arrive already informed by podcasts, wearables, and direct-to-consumer epigenetic testing, asking about GLP-1 receptor agonists, biological age, senolytics, and rapamycin, and they expect their physician to keep pace. The question is no longer whether patients want longevity medicine. It's whether your practice is ready to lead or content to follow.
Signal 2: The Science Has Reached Clinical Readiness
Epigenetic clocks (Horvath, GrimAge, DunedinPoAm) now measure biological age with clinical precision. Multi-omics profiling reveals aging mechanisms at scale. Senolytics, GLP-1 agonists, and peptide therapies move from research to clinical application. The field is built on measurement, evidence, and implementation. This is no longer speculative.
Signal 3: The Physician Gap Is Structural
Every longevity technology company, health system, and insurance provider hits the same wall: physicians are easy to find; physicians trained specifically in longevity medicine are rare. Most bring deep expertise in disease management, built over years of residency and practice. What's missing is mechanism-level training in aging biology, biomarker assessment, and precision intervention design, the actual foundation longevity medicine requires.
This credential gap is your opportunity. Physicians who transition to longevity medicine now are building practice differentiation that will compound for the next decade.
The Clinical Role: What a Longevity Physician Does
Assessment: Biological Age & Mechanism Mapping
A longevity physician begins with comprehensive biological assessment. Epigenetic clocks measure true aging rate. Advanced biomarker panels reveal inflammatory status, metabolic health, cardiovascular risk. Multi-omics profiling (genomics, proteomics, metabolomics) identifies mechanism-specific aging patterns. Imaging (CIMT, coronary CT, DEXA) captures structural aging. Wearables provide continuous biometric data.
From this data architecture, the longevity physician constructs a biological age profile. Not just "patient is 55 years old." Rather: "Biological age is 58 (aging faster than chronological). Primary mechanisms: increased inflammaging (IL-6 elevated), mitochondrial stress (NAD+ depleted), cellular senescence (p16 elevated). Secondary mechanisms: telomere shortening, epigenetic drift in aging-related loci."
Protocol Design: Targeted Mechanism Intervention
The longevity physician prescribes interventions calibrated to mechanism:
-
Inflammaging protocol: GLP-1 receptor agonist (mechanism: reduces monocyte activation, shifts IL-6 downward); targeted supplementation (quercetin for senolytic effect); fasting protocol (enhances autophagy, clears senescent cells)
-
Mitochondrial dysfunction protocol: NAD+ precursor (NMN or NR to restore NAD+ synthesis); CoQ10 + PQQ (electron transport chain support); HBOT (improves mitochondrial biogenesis); targeted exercise (activates SIRT3)
-
Cellular senescence protocol: Senolytics (dasatinib + quercetin) on intermittent schedule; peptides (GHK-Cu, thymosin alpha-1) to drive senescent cell clearance; fasting to enhance autophagy
-
Epigenetic drift protocol: Methyl donors (TMG, folate); SIRT1 activators (resveratrol, NMN); stress management (cortisol is a primary driver of epigenetic aging)
Every intervention is prescribed with specificity.
Monitoring: Continuous Outcome Tracking
The longevity physician does not prescribe once and disappear. They monitor continuously: repeat epigenetic clocks (annually or bi-annually to assess aging trajectory), updated biomarker panels (quarterly to track mechanism-specific response), patient-reported outcomes (functional capacity, energy, cognition), protocol adherence (which interventions is the patient actually using).
Protocols iterate based on evidence and this precision medicine is applied to aging.
The 10 Pillars: Standards That Define a Trusted Longevity Physician
From conversations with hundreds of physicians transitioning to longevity medicine, Dr. David Luu, MD™ identified core standards separating trusted longevity physicians from wellness practitioners. These 10 pillars define the discipline and how to become a longevity physician:
1. Reframe Your Clinical Identity
You are no longer just a cardiologist, dermatologist, or internist. You are a longevity cardiologist, longevity dermatologist, longevity physician. Your identity shifts from managing disease to optimizing aging. This is real. It requires owning the identity and the responsibility that comes with it.
2. Master Aging Biology at Mechanism Level
Understanding hallmarks of aging, longevity pathways (mTOR, sirtuins, AMPK, Klotho, NAD+ metabolism), geroprotective interventions, novel biomarkers, and emerging therapeutics is imperative. Know what is validated science, what is research-grade, what is speculative. This knowledge difference is the difference between a trusted physician and a wellness influencer.
3. Lead With Evidence, Navigate Uncertainty Honestly
RCTs are rare in early-stage longevity medicine. Real-world evidence is often more relevant. Yet physicians need solutions now. Navigate the spectrum: published studies, consensus statements, expert interpretation. Be transparent when evidence is emerging. Admit what you don't know. Patients respect honest uncertainty more than false confidence.
4. Establish Your Own Clinical Standards
Guidelines don't exist yet. You need to establish what's generally accepted as good practice in your specialty adapted for aging mechanisms. Document your protocols. Make them defensible. Share them with peers for critique. Standards emerge from community, not isolation.
5. Update Your Technology Stack Intentionally
Traditional EMRs were built for coding and billing. Longevity medicine requires: AI diagnostics for aging trajectory modeling, wearables integration (CGM, heart rate variability), novel biomarker platforms (epigenetic clocks, omics), precision lab ordering systems. Build a curated tech stack. Audit for accuracy. Integrate intentionally, not haphazardly.
6. Establish Clear Ethical Governance
Clear informed consent. Explicit risk disclosure. Clear limits on your scope. Documented conflict-of-interest policies. When prescribing off-label (senolytics, peptides, rapamycin), document informed consent explicitly. Disclose financial relationships with supplement companies. Define boundaries with transparency. Your ethical framework protects both patients and the field's credibility.
7. Educate Your Patients: Build Longevity Literacy
Help patients understand their biomarkers, the mechanistic rationale behind interventions, realistic timelines for biological age reversal. Give them the vocabulary to evaluate claims they see online. This is the only way to win trust and differentiate yourself from wellness marketing.
8. Build Operational Excellence
Hire and train teams who understand longevity protocols. Write SOPs. Design patient experience workflows. Build communication systems. Onboard staff to interpret novel biomarkers, standardize how you communicate aging assessment results, document protocol iteration. Operations are how you scale.
9. Optimize Economics: Build a Sustainable Practice
Get pricing right. Moving from a payroll to a sustainable private practice is challenging. Building a profitable, sustainable practice is the only path to democratizing longevity medicine. We need good, well-trained doctors incentivized on outcomes, not supplement margins. Economics matter. Don't ignore them.
10. Stay Connected to Community
No credible physician practices alone. Join the longevitydocs network of 1,200+ physicians across 68+ countries. Build a referral system. Engage peers for case consults. Standards emerge from community. Local and global mentorship accelerates your learning and execution by months.
Practice Models: Financial Reality for Longevity Physicians
Concierge Longevity Practice
Model: Limited patient panel (100–300), retainer-based, premium fees, personalized care
Revenue per patient: $5,000–$25,000/year retainer (typically $10,000–$15,000 for mature practice)
Annual revenue potential: $500K–$3.5M (depending on panel size, retainer amount)
Overhead breakdown: Biomarker costs (20–30%), staff (25–35%), rent/facilities (10–15%), tech (5–10%), continuing education (2–5%) = ~40–50% overhead, leaving 50–60% net margin at scale
Timeline to profitability: Month 6–12 (patient acquisition is the constraint; once panel is full, margins are exceptional)
Best for: Physicians with high-net-worth patient access, geographic desirability, or existing referral network
Hybrid Longevity Practice
Model: Traditional primary care + longevity services offered à la carte or as premium tier
Revenue per longevity visit: $500–$2,000 (comprehensive assessment); $200–$500 (follow-up monitoring)
Annual revenue potential: $150K–$400K (blended with traditional primary care revenue)
Overhead: Shared with primary care practice; biomarker costs still 20–30% of longevity revenue
Timeline to profitability: Month 3–6 (integrates into existing cash flow)
Best for: Physicians already running primary care practices, geographic markets where concierge is not viable, practices wanting to transition gradually
Telemedicine Longevity Practice
Model: Virtual-first, direct-to-consumer, AI-supported (Hippo AI lightens assessment load)
Revenue per patient: $100–$500/visit; some use subscription model ($99–$299/month)
Annual revenue potential: $75K–$250K (low overhead makes scaling easier)
Overhead: Minimal; mostly tech and payment processing (10–15% of revenue)
Timeline to profitability: Month 3–4 (fastest to profitability due to low overhead)
Best for: Physicians building geographic reach, early-stage practices scaling fast, physicians testing market before committing to full practice model
RECENT CLD GRADUATES on why longevity medicine certification is important to the field and the roi
The Certified longevitydocs.™ CLD trains physicians around the world across a spectrum of specialities; longevity is a natural extension of any medical lens, and we're building this reality together here.
Our CLD graduates range from early-career physicians just entering longevity medicine to 20+ year practitioners transforming established practices, and they come from diverse backgrounds including academic medicine, private practice, and hybrid models. They all complete the same 100+ hour curriculum, and their outcomes differ as their vision for longevity medicine is individual, the true ROI is theirs to define. Read on for the stories of how four physicians used the CLD longevity medicine training to build unique outcomes:
Why Every DOCTOR Should Be a Longevity Doctor.™ Now
Market Timing: The Window Is Open
Longevity medicine is moving from emerging to established. Insurance will follow evidence; standards will mature; medical schools will integrate aging biology. The physicians who transition now are building first-mover advantage. In 5 years, longevity medicine will be table stakes. In 10 years, it will be standard. The question is whether you lead or follow.
Patient Demand Is Non-Negotiable
Your patients are already asking. GLP-1s for longevity (not just diabetes), epigenetic testing, senolytics, rapamycin for aging, biological age assessment. Patients are self-educating faster than medical education is evolving. Your patients expect you to be ready. If you're not, they will find a physician who is.
Differentiation That Compounds
Longevity medicine is a clinical specialization that sets you apart in a crowded market. Patients seek physicians who understand their aging biology. Referring physicians respect physicians who think mechanistically about prevention, not just disease treatment. This differentiation compounds: early patients refer friends; reputation builds; practice strengthens.
Practice Economics
Longevity practices operate on higher margins than traditional medicine. Concierge model: 50–60% net margin at scale. Hybrid model: 30–40% incremental margin on longevity revenue. Telemedicine: 70%+ net margin due to low overhead. Longevity medicine is operationally efficient and financially sustainable. Read on for more information of practice models.
Frequently Asked Questions: Longevity Physicians
What is the difference between a longevity physician and a gerontologist?
Gerontologists manage disease in older adults (Alzheimer's, osteoporosis, frailty). Longevity physicians work further upstream, addressing cellular senescence, mitochondrial dysfunction, and inflammaging before disease emerges. Gerontology is reactive disease management; longevity is proactive aging optimization. Different specializations, complementary fields.
Do I need to leave my current specialty to become a longevity physician?
No. You become a longevity [your specialty]. A cardiologist becomes a longevity cardiologist, applying aging biology to cardiovascular optimization. A dermatologist becomes a longevity dermatologist, addressing skin aging at the mechanism level. Your speciality has a natural longevity extension.
How long does it take to become a longevity physician?
How much do longevity physicians earn?
Varies by model. Concierge: $300K–$750K/year (after overhead). Hybrid: $150K–$400K/year (incremental longevity revenue). Telemedicine: $75K–$250K/year (low overhead).
What credential should I pursue: CLD, A4M, or ABLM?
CLD: Fastest (6–9 months), peer-networked, full curriculum access at enrollment, curated 20-30 person cohorts, longevitydocs.™ platform access, business benefits include operational infrastructure, ideal for a practice launch and strong community. A4M: Longer (12–24 months), exam-based, fellowship structure. ABLM: Most formal (18–36 months), board certification path. Choose based on timeline, learning preference, price, and goals.
Is longevity medicine evidence-based?
Yes. Grounded in aging biology (hallmarks, pathways, biomarkers proven in peer-reviewed research). Interventions (GLP-1 for inflammaging, senolytics for senescence, rapamycin for mTOR) are based on clinical trials and mechanistic understanding. Some emerging therapies lack large-scale RCTs, but trusted longevity physicians lead with data and acknowledge evidence gaps honestly.
How do I build my first longevity patient cohort?
Start with existing patients interested in prevention. Pilot with 10–15 patients. Refine protocols. Get outcomes (biomarkers improve, biological age reverses). Share success stories within your referral network. Market to health-conscious, high-net-worth populations. Build referral partnerships with other longevity physicians.
What is the longevitydocs network?
Can I integrate longevity medicine into an existing practice?
Yes. Most physicians transition by: (1) Completing longevity credential (6–9 months). (2) Setting up vendor partnerships (3–6 months). (3) Training staff on protocols (ongoing). (4) Gradually offering longevity services to existing patients (month 3+). Timeline to meaningful longevity revenue: 6–12 months. Hybrid model minimizes disruption.
What biomarkers should I use for biological age assessment?
Epigenetic clocks (Horvath, GrimAge, DunedinPoAm) measure biological aging rate. Advanced biomarkers include: inflammatory (IL-6, TNF-alpha, hsCRP), metabolic (fasting insulin, HbA1c), cardiovascular (Lp(a), apoB), immune (lymphocyte counts), organ-specific (eGFR, ALT). Omics profiling (proteomics, metabolomics) reveals mechanism-specific patterns. Combine multiple biomarker layers for precision assessment.
How do I stay current with emerging longevity science?
Join the longevitydocs.™ network for monthly faculty briefings on emerging research. Subscribe to peer-reviewed journals (Cell, Nature, Aging Cell, GeroScience). Engage with leading aging-research institutions. Attend the annual longevitydocs.™ Cannes summit or Mastermind events. Participate in peer consultation channels for real-time case discussions.
What is the difference between biological age and chronological age?
Chronological age is years lived. Biological age is how old your cells actually are, measured via epigenetic clocks, biomarker panels, and omics analysis. A 55-year-old might have biological age of 50 (aging slower) or 60 (aging faster). Longevity physicians measure biological age to assess true aging rate, predict disease risk, and track whether interventions slow aging.
How do I explain longevity medicine to skeptical colleagues?
Lead with mechanism and evidence. Aging is biology, not fate. Hallmarks of aging are documented (cellular senescence, mitochondrial dysfunction, inflammaging). Interventions targeting these mechanisms improve outcomes (GLP-1 reduces inflammaging; senolytics clear senescent cells; NAD+ precursors restore mitochondrial function). Point to real physician outcomes: 1,200+ physicians in the network, documented biomarker improvements, growing practice profitability.
Is longevity medicine covered by insurance?
Some preventive components (lifestyle counseling, some biomarkers) may be covered. Most longevity-specific services (epigenetic clocks, comprehensive aging assessment, senolytics, peptide protocols) are direct-pay or membership-based.
How do I know if a longevity physician is trustworthy?
Look for: MD/DO/MBBS license verification, completed credential (CLD, A4M, or ABLM), membership in recognized network (longevitydocs, A4M), peer reviews from other physicians, documented patient outcomes (biomarker improvements, published case studies), transparent about evidence gaps, clear informed consent for off-label interventions, no conflicts of interest with supplement companies.
What should I expect in my first year of longevity practice?
While every practice is different and you design your outcomes as part of your training, a common path may look like this:
Months 1–3: Credential completion, vendor setup, staff training. Months 3–6: First patients, protocol refinement, biomarker tracking. Months 6–12: Growing patient panel, iterating based on outcomes, building referral partnerships. Revenue: $50K–$150K (acquisition phase). By year 2: $200K–$400K
(depending on model). Focus on outcomes and reputation; revenue follows.
The Path Forward: Every Physician Can Lead
Longevity medicine is here. The only question is who leads it.
If you believe longevity medicine deserves the same rigor as any specialty, get certified. If you want to help advance its standards and work with peers and the cutting edge, join the community. If you're generating outcomes, contribute to the research. If you believe longevity medicine is real medicine, practice it the way you intend.
We are choosing to lead. Every physician can. The infrastructure, the network, the evidence, and the marketplace are ready.
Every Doctor Should Be A Longevity Doctor™
What Is a Longevity Doctor? Definition, Role and Why Every Physician Should be One
EDUCATION
What Is a Longevity Doctor? Definition, Role & Why Every Physician Should be One
Longevity medicine is a natural extension of nearly every speciality of medicine: practiced by physicians, grounded in evidence, and accountable to professional standards. Here's what a longevity doctor actually does, why physicians are transitioning now, and how this specialization is reshaping clinical practice.
The Clinical Definition: What Is a Longevity Doctor?
A longevity doctor is a licensed physician (MD, DO, or MBBS) trained in aging biology and dedicated to extending healthspan through evidence-based interventions targeting the mechanisms of aging. Unlike traditional physicians who diagnose and treat disease after it emerges, a longevity physician assesses biological age and intervenes before disease develops.
Longevity medicine is real medicine: practiced by physicians, grounded in evidence, and accountable to professional standards. The wellness field gets confused with wellness theater, optimization trends, and the biohacking content flooding social media often enough that the distinction is worth making explicit.
A longevity physician understands the hallmarks of aging: cellular senescence, mitochondrial dysfunction, inflammaging, telomere attrition, epigenetic drift, loss of proteostasis, disabled macroautophagy, stem cell exhaustion, and altered intercellular communication. Just as important, they know how to translate that understanding into clinical practice: assessing biological age with objective biomarkers, prescribing interventions based on mechanism rather than marketing, documenting outcomes, and staying accountable to professional standards.
Why This Matters Now: The Market Signal
Signal 1: Patient Demand Has Already Arrived
Patients arrive already informed by podcasts, wearables, and direct-to-consumer epigenetic testing, asking about GLP-1 receptor agonists, biological age, senolytics, and rapamycin, and they expect their physician to keep pace. The question is no longer whether patients want longevity medicine. It's whether your practice is ready to lead or content to follow.
Signal 2: The Science Has Reached Clinical Readiness
Epigenetic clocks (Horvath, GrimAge, DunedinPoAm) now measure biological age with clinical precision. Multi-omics profiling reveals aging mechanisms at scale. Senolytics, GLP-1 agonists, and peptide therapies move from research to clinical application. The field is built on measurement, evidence, and implementation. This is no longer speculative.
Signal 3: The Physician Gap Is Structural
Every longevity technology company, health system, and insurance provider hits the same wall: physicians are easy to find; physicians trained specifically in longevity medicine are rare. Most bring deep expertise in disease management, built over years of residency and practice. What's missing is mechanism-level training in aging biology, biomarker assessment, and precision intervention design, the actual foundation longevity medicine requires.
This credential gap is your opportunity. Physicians who transition to longevity medicine now are building practice differentiation that will compound for the next decade.
The Clinical Role: What a Longevity Physician Does
Assessment: Biological Age & Mechanism Mapping
A longevity physician begins with comprehensive biological assessment. Epigenetic clocks measure true aging rate. Advanced biomarker panels reveal inflammatory status, metabolic health, cardiovascular risk. Multi-omics profiling (genomics, proteomics, metabolomics) identifies mechanism-specific aging patterns. Imaging (CIMT, coronary CT, DEXA) captures structural aging. Wearables provide continuous biometric data.
From this data architecture, the longevity physician constructs a biological age profile. Not just "patient is 55 years old." Rather: "Biological age is 58 (aging faster than chronological). Primary mechanisms: increased inflammaging (IL-6 elevated), mitochondrial stress (NAD+ depleted), cellular senescence (p16 elevated). Secondary mechanisms: telomere shortening, epigenetic drift in aging-related loci."
Protocol Design: Targeted Mechanism Intervention
The longevity physician prescribes interventions calibrated to mechanism:
Every intervention is prescribed with specificity.
Monitoring: Continuous Outcome Tracking
The longevity physician does not prescribe once and disappear. They monitor continuously: repeat epigenetic clocks (annually or bi-annually to assess aging trajectory), updated biomarker panels (quarterly to track mechanism-specific response), patient-reported outcomes (functional capacity, energy, cognition), protocol adherence (which interventions is the patient actually using).
Protocols iterate based on evidence and this precision medicine is applied to aging.
The 10 Pillars: Standards That Define a Trusted Longevity Physician
From conversations with hundreds of physicians transitioning to longevity medicine, Dr. David Luu, MD™ identified core standards separating trusted longevity physicians from wellness practitioners. These 10 pillars define the discipline and how to become a longevity physician:
1. Reframe Your Clinical Identity
You are no longer just a cardiologist, dermatologist, or internist. You are a longevity cardiologist, longevity dermatologist, longevity physician. Your identity shifts from managing disease to optimizing aging. This is real. It requires owning the identity and the responsibility that comes with it.
2. Master Aging Biology at Mechanism Level
Understanding hallmarks of aging, longevity pathways (mTOR, sirtuins, AMPK, Klotho, NAD+ metabolism), geroprotective interventions, novel biomarkers, and emerging therapeutics is imperative. Know what is validated science, what is research-grade, what is speculative. This knowledge difference is the difference between a trusted physician and a wellness influencer.
3. Lead With Evidence, Navigate Uncertainty Honestly
RCTs are rare in early-stage longevity medicine. Real-world evidence is often more relevant. Yet physicians need solutions now. Navigate the spectrum: published studies, consensus statements, expert interpretation. Be transparent when evidence is emerging. Admit what you don't know. Patients respect honest uncertainty more than false confidence.
4. Establish Your Own Clinical Standards
Guidelines don't exist yet. You need to establish what's generally accepted as good practice in your specialty adapted for aging mechanisms. Document your protocols. Make them defensible. Share them with peers for critique. Standards emerge from community, not isolation.
5. Update Your Technology Stack Intentionally
Traditional EMRs were built for coding and billing. Longevity medicine requires: AI diagnostics for aging trajectory modeling, wearables integration (CGM, heart rate variability), novel biomarker platforms (epigenetic clocks, omics), precision lab ordering systems. Build a curated tech stack. Audit for accuracy. Integrate intentionally, not haphazardly.
6. Establish Clear Ethical Governance
Clear informed consent. Explicit risk disclosure. Clear limits on your scope. Documented conflict-of-interest policies. When prescribing off-label (senolytics, peptides, rapamycin), document informed consent explicitly. Disclose financial relationships with supplement companies. Define boundaries with transparency. Your ethical framework protects both patients and the field's credibility.
7. Educate Your Patients: Build Longevity Literacy
Help patients understand their biomarkers, the mechanistic rationale behind interventions, realistic timelines for biological age reversal. Give them the vocabulary to evaluate claims they see online. This is the only way to win trust and differentiate yourself from wellness marketing.
8. Build Operational Excellence
Hire and train teams who understand longevity protocols. Write SOPs. Design patient experience workflows. Build communication systems. Onboard staff to interpret novel biomarkers, standardize how you communicate aging assessment results, document protocol iteration. Operations are how you scale.
9. Optimize Economics: Build a Sustainable Practice
Get pricing right. Moving from a payroll to a sustainable private practice is challenging. Building a profitable, sustainable practice is the only path to democratizing longevity medicine. We need good, well-trained doctors incentivized on outcomes, not supplement margins. Economics matter. Don't ignore them.
10. Stay Connected to Community
No credible physician practices alone. Join the longevitydocs network of 1,200+ physicians across 68+ countries. Build a referral system. Engage peers for case consults. Standards emerge from community. Local and global mentorship accelerates your learning and execution by months.
Practice Models: Financial Reality for Longevity Physicians
Concierge Longevity Practice
Model: Limited patient panel (100–300), retainer-based, premium fees, personalized care
Revenue per patient: $5,000–$25,000/year retainer (typically $10,000–$15,000 for mature practice)
Annual revenue potential: $500K–$3.5M (depending on panel size, retainer amount)
Overhead breakdown: Biomarker costs (20–30%), staff (25–35%), rent/facilities (10–15%), tech (5–10%), continuing education (2–5%) = ~40–50% overhead, leaving 50–60% net margin at scale
Timeline to profitability: Month 6–12 (patient acquisition is the constraint; once panel is full, margins are exceptional)
Best for: Physicians with high-net-worth patient access, geographic desirability, or existing referral network
Hybrid Longevity Practice
Model: Traditional primary care + longevity services offered à la carte or as premium tier
Revenue per longevity visit: $500–$2,000 (comprehensive assessment); $200–$500 (follow-up monitoring)
Annual revenue potential: $150K–$400K (blended with traditional primary care revenue)
Overhead: Shared with primary care practice; biomarker costs still 20–30% of longevity revenue
Timeline to profitability: Month 3–6 (integrates into existing cash flow)
Best for: Physicians already running primary care practices, geographic markets where concierge is not viable, practices wanting to transition gradually
Telemedicine Longevity Practice
Model: Virtual-first, direct-to-consumer, AI-supported (Hippo AI lightens assessment load)
Revenue per patient: $100–$500/visit; some use subscription model ($99–$299/month)
Annual revenue potential: $75K–$250K (low overhead makes scaling easier)
Overhead: Minimal; mostly tech and payment processing (10–15% of revenue)
Timeline to profitability: Month 3–4 (fastest to profitability due to low overhead)
Best for: Physicians building geographic reach, early-stage practices scaling fast, physicians testing market before committing to full practice model
RECENT CLD GRADUATES on why longevity medicine certification is important to the field and the roi
The Certified longevitydocs.™ CLD trains physicians around the world across a spectrum of specialities; longevity is a natural extension of any medical lens, and we're building this reality together here.
Our CLD graduates range from early-career physicians just entering longevity medicine to 20+ year practitioners transforming established practices, and they come from diverse backgrounds including academic medicine, private practice, and hybrid models. They all complete the same 100+ hour curriculum, and their outcomes differ as their vision for longevity medicine is individual, the true ROI is theirs to define. Read on for the stories of how four physicians used the CLD longevity medicine training to build unique outcomes:
Why Every DOCTOR Should Be a Longevity Doctor.™ Now
Market Timing: The Window Is Open
Longevity medicine is moving from emerging to established. Insurance will follow evidence; standards will mature; medical schools will integrate aging biology. The physicians who transition now are building first-mover advantage. In 5 years, longevity medicine will be table stakes. In 10 years, it will be standard. The question is whether you lead or follow.
Patient Demand Is Non-Negotiable
Your patients are already asking. GLP-1s for longevity (not just diabetes), epigenetic testing, senolytics, rapamycin for aging, biological age assessment. Patients are self-educating faster than medical education is evolving. Your patients expect you to be ready. If you're not, they will find a physician who is.
Differentiation That Compounds
Longevity medicine is a clinical specialization that sets you apart in a crowded market. Patients seek physicians who understand their aging biology. Referring physicians respect physicians who think mechanistically about prevention, not just disease treatment. This differentiation compounds: early patients refer friends; reputation builds; practice strengthens.
Practice Economics
Longevity practices operate on higher margins than traditional medicine. Concierge model: 50–60% net margin at scale. Hybrid model: 30–40% incremental margin on longevity revenue. Telemedicine: 70%+ net margin due to low overhead. Longevity medicine is operationally efficient and financially sustainable. Read on for more information of practice models.
Frequently Asked Questions: Longevity Physicians
While every practice is different and you design your outcomes as part of your training, a common path may look like this:
The Path Forward: Every Physician Can Lead
Longevity medicine is here. The only question is who leads it.
If you believe longevity medicine deserves the same rigor as any specialty, get certified. If you want to help advance its standards and work with peers and the cutting edge, join the community. If you're generating outcomes, contribute to the research. If you believe longevity medicine is real medicine, practice it the way you intend.
We are choosing to lead. Every physician can. The infrastructure, the network, the evidence, and the marketplace are ready.
Every Doctor Should Be A Longevity Doctor™
Ready to Lead in Longevity Medicine?
Join 1,200+ physicians building the future of clinical longevity medicine. Become a Certified longevitydocs physician in 6–9 months.
30 seats open now. Apply to enroll.
This article is published exclusively for licensed physicians and qualified healthcare professionals. It is not intended for consumers or patients.
All content is for continuing medical education and professional information purposes only. It reflects emerging research, science, and technology that may have implications for the practice of medicine. It does not constitute medical advice, clinical recommendations, or treatment guidance for any individual patient.
By reading this article, you confirm that you are a licensed healthcare professional and that you will apply the information contained herein within the bounds of your clinical judgment, professional obligations, and applicable regulations.